Augustine Therapeutics raises €17M in series A first closing (NYSE:LLY)
manassanant pamai Augustine Therapeutics, focused on novel treatments for neurodegenerative and cardio metabolic diseases, Wednesday said that it has raised €17 million ($18.5 million) in the first closing of its Series A round. The financing was led by Asabys Partners, with participation from Eli Lilly and Company (NYSE:LLY), and theContinue Reading